Clinical Trials Directory

Trials / Unknown

UnknownNCT05588037

Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery

Clinical Assessment of Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Aier School of Ophthalmology, Central South University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Based on the progress of cataract surgery, intraocular lens development, vitreoretinal surgery and anesthesia technology in recent years, the purpose of this study is to develop a new type of more accurate and minimally invasive combined surgery for cataract and fundus diseases, and to evaluate the advantages and value of the surgery as well as related complications, so as to minimize the surgical trauma and obtain faster visual function recovery and better patient comfort. To provide new solutions for the growing demand of eye health care.

Detailed description

To evaluate the efficacy and complications of a new type of minimally invasive femtosecond laser assisted-cataract surgery (FLACS) combined with pars plana vitrectomy (PPV) with two-step anesthesia in the treatment of various common fundus diseases such as rhegmatogenous retinal detachment (RRD), epiretinal membrane (ERM), macular hole (MH), and vitreous opacity, complicated with cataract. It is mainly aimed at the following kinds of common fundus diseases with cataract performing PPV and cataract removal combined with monofocal or premium intraocular lens (IOL) implantation: RRD complicated with cataract: FLACS +PPV + IOL+air; ERM complicated with cataract: FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex; MH complicated with cataract: FLACS + PPV+ IOL + internal limiting membrane peeling + air; Vitreous opacity with cataract: FLACS + PPV+ IOL.

Conditions

Interventions

TypeNameDescription
PROCEDUREFLACS +PPV+IOL + airThe procedures are combined the FLACS +PPV+IOL + air.
PROCEDUREFLACS +PPV+IOL + epiretinal membrane peeling + OzurdexThe procedures are combined the FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex.
PROCEDUREFLACS + PPV+IOL + internal limiting membrane peeling + airThe procedures are combined the FLACS + PPV+IOL + internal limiting membrane peeling + air.
PROCEDUREFLACS + PPV+IOLThe procedures are combined the FLACS + PPV+IOL.

Timeline

Start date
2017-01-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2022-10-20
Last updated
2022-10-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05588037. Inclusion in this directory is not an endorsement.